VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot 3CA55C1: VAERS reports
33 VAERS reports list lot 3CA55C1 as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2025-04-24 and 2026-03-27. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 18 | 62% |
| Dermatological (non-injection-site) | 4 | 14% |
| Allergic / Anaphylactic | 3 | 10% |
| Musculoskeletal | 2 | 7% |
| Respiratory | 1 | 3% |
| General / Systemic (non-local) | 1 | 3% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Nevada | 6 |
| Washington | 6 |
| Michigan | 4 |
| Ohio | 3 |
| Tennessee | 2 |
| Utah | 2 |
| Florida | 2 |
| North Carolina | 1 |
| Arkansas | 1 |
| Illinois | 1 |
| Idaho | 1 |
| New York | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2025-04 | 2 | |
| 2025-06 | 3 | |
| 2025-07 | 2 | |
| 2025-08 | 9 | |
| 2025-09 | 5 | |
| 2025-10 | 6 | |
| 2025-12 | 1 | |
| 2026-01 | 1 | |
| 2026-02 | 2 | |
| 2026-03 | 2 |
Products recorded with this lot
- DTaP — Sanofi Pasteur (33 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): 3CA03C3 · 3CA20C1 · 3CA25C1 · C2340AA · C2341AA · C2384AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.